Indication
Primary Hyperoxaluria
5 clinical trials
2 products
Clinical trial
A Phase 2 Open-Label Multicenter Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Nedosiran in Pediatric Patients From Birth to 11Years of Age With Primary Hyperoxaluria and Relatively Intact Renal FunctionStatus: Recruiting, Estimated PCD: 2024-12-01
Product
nedosiranClinical trial
Expanded Access Protocol to Provide Lumasiran to Patients With Primary Hyperoxaluria Type 1Status:
Product
LumasiranClinical trial
ILLUMINATE-B: An Open-Label Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1Status: Active (not recruiting), Estimated PCD: 2020-06-29
Clinical trial
ILLUMINATE-C: A Single Arm Study to Evaluate Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 (PH1)Status: Active (not recruiting), Estimated PCD: 2021-05-18
Clinical trial
A Phase 2, Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Administration of ALN-GO1 in Patients With Primary Hyperoxaluria Type 1Status: Completed, Estimated PCD: 2023-02-07